TAP-311

N/A

Report date: 2023/10/17 16:47:27
NME

Base Information

Drug NameTAP-311
Drug Alias NameTAP-311
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanJordan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsDyslipidemias

Other Information

ATC CodeN/A
Related LinksN/A